Reversible inhibitors of the gastric (H+/K+)-ATPase. 4. Identification of an inhibitor with an intermediate duration of action

Article abstract of DOI:10.1021/jm00014a026

3-Acyl-4-(arylamino)quinolines were previously identified as gastric (H⁺/K⁺)-ATPase inhibitors, and clinical efficacy has been demonstrated for compound 3 (SK and F 96067). In the present study the further structure- activity relatio